ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,561,328 | +30.0% | 511,073 | 0.0% | 0.13% | +14.7% |
| Q2 2023 | $1,201,022 | -19.0% | 511,073 | 0.0% | 0.12% | +1.8% |
| Q1 2023 | $1,482,112 | +19.7% | 511,073 | 0.0% | 0.11% | +42.5% |
| Q4 2022 | $1,238,688 | -13.4% | 511,073 | 0.0% | 0.08% | -14.0% |
| Q3 2022 | $1,431,000 | – | 511,073 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,066,290 | $11,905,782 | 7.44% |
| LVW Advisors, LLC | 672,331 | $1,579,978 | 0.30% |
| Praetorian PR LLC | 180,005 | $423,012 | 0.26% |
| Nantahala Capital Management | 511,073 | $1,201,022 | 0.12% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $938,165 | 0.06% |
| Ikarian Capital, LLC | 156,203 | $340,523 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,319 | $40,700 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,101 | $14,337 | 0.00% |
| ROYAL BANK OF CANADA | 48 | $0 | 0.00% |
| VANGUARD GROUP INC | 16,032 | $37,675 | 0.00% |